Home  >  Products  >  DOC2A (double C2-like domains, alpha ) Blocking Peptide (the N terminal of DOC2A)(100ug)
DOC2A (double C2-like domains, alpha ) Blocking Peptide (the N terminal of DOC2A)(100ug)

DOC2A (double C2-like domains, alpha ) Blocking Peptide (the N terminal of DOC2A)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-DOC2A Antibody (ARP64731_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP64731
Size: 100ug
Weight: 44kDa
Gene: 8448
Format: Lyophilized powder
Target: There are at least two protein isoforms of the Double C2 protein, namely alpha (DOC2A) and beta (DOC2B), which contain two C2-like domains. DOC2A and DOC2B are encoded by different genes; these genes are at times confused with the unrelated DAB2 gene which was initially named DOC-2. DOC2A is mainly expressed in brain and is suggested to be involved in Ca(2+)-dependent neurotransmitter release.
See Full Product Listings >